https://canceradvocacy.org/wp-content/uploads/Laurel-Braitman-Advocate-Spotlight-Blog-Banner.jpg
600
1200
Elleni
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Horiz_TwoColor.svg
Elleni2025-11-19 15:35:512025-11-19 16:07:28The Meaning We Make: Laurel Braitman’s Path from Co-Survivor to AdvocateNCCS is now Cancer Nation. Find out more about our next chapter. Join Us
News
https://canceradvocacy.org/wp-content/uploads/Laurel-Braitman-Advocate-Spotlight-Blog-Banner.jpg
600
1200
Elleni
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Horiz_TwoColor.svg
Elleni2025-11-19 15:35:512025-11-19 16:07:28The Meaning We Make: Laurel Braitman’s Path from Co-Survivor to Advocate
Cancer Nation Releases Survivorship Survey 2025 Results
Cancer Nation worked with Edge Research to conduct our seventh annual nationwide survey of cancer survivors, exploring their experiences…

Statement on Dr. Richard Pazdur Being Named FDA Center for Drug Evaluation and Research Director
November 13, 2025 – Cancer Nation applauds the choice of Dr. Richard Pazdur as the Director of the Center for Drug Evaluation and…

Webinar – Navegando la terapia de células T con CAR: su camino hacia la recuperación
La serie de seminarios web de Cáncer Nation presenta “Navegando la terapia de células T con CAR: su camino hacia la recuperación”,…

30+ Patient Orgs Urge Congress to Extend Health Care Tax Credits Immediately
Cancer Nation and more than 30 other patient advocacy organizations are calling on Congress to immediately renew the enhanced premium…

Webinar – Navigating CAR T-Cell Therapy: Your Journey to Recovery
Cancer Nation's Webinar Series presents "Navigating CAR T-Cell Therapy: Your Journey to Recovery," a conversation about the journey…

Protect Our Health Care: Tell Congress to Extend ACA Tax Credits
Millions Could Lose Health Coverage if Congress Fails to Act
22 million Americans rely on Affordable Care Act (ACA) premium tax…

Webinar: Navigating Communication on Clinical Trials in Oncology
Effective communication between patients and oncologists is essential to ensure understanding, participation, and optimal outcomes. This webinar discusses the role of communication in clinical trial participation. Viewers will gain insight into how communication can influence trial participation, improve patient understanding, and address concerns such as eligibility, side effects, and informed consent.

